The analysis of the NHL transcriptome from n = 624 lymphoma patients showing upregulations in the expression of FASN nucleotide metabolic genes, but not with those of oxidative PPP in the presence of lymphomagenic mutations (Figure 7), underpins the necessity of FASN to function as a metabolic driver of nucleotide synthesis in cancer. The gene discussed is FASN; the disease is cancer.